Danaparoid and haemorrhage Patient Reports February 10, 2010

Danaparoid Side Effects Report #5314613-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2004. Male patient, 64 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: abdominal pain , adrenal insufficiency, circulatory collapse, confusional state, haemorrhage, heparin-induced thrombocytopenia, necrosis, pyrexia, urine sodium increased. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.

Danaparoid Side Effects Report #5102731-7
Danaparoid side effect was reported by a Consumer or non-health professional from GERMANY on Aug 31, 2006. Female patient was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.

Danaparoid Side Effects Report #5086058-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5124739-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 21, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.


Danaparoid Side Effects Report #5042515-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 18, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5102723-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 15, 2006. Male patient, 87 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PROPOFOL, DOPAMINE, METHYLPREDNISOLONE SUCCINATE, ANTITHROMBIN III, DOBUTAMINE, NOREPINEPHRINE BITARTRATE, MEROPENEM TRIHYDRATE, IMMUNE GLOBULIN INTRAVENOUS. Patient recovered.

Danaparoid Side Effects Report #5042516-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2006. Male patient, 86 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemorrhage, infection . Danaparoid dosage: unknown. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, CARBENIN, ULINASTATIN, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5031765-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, IMMUNE GLOBULIN INTRAVENOUS, MICAFUNGIN, PLASMA PROTEIN FRACTION, GABEXATE MESILATE, PLATELETS, MINOCYCLINE HYDROCHLORIDE, CEFPIROME SULPHATE. Patient died.

Danaparoid Side Effects Report #5031769-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 13, 2005. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemorrhage, infection . Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIME HYDROCHLORIDE, MEROPENEM, AMINO ACIDS NOS W, SIVELESTAT, OMEPRAZOLE. Patient died.


Danaparoid Side Effects Report #5047256-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: catheter related complication, condition aggravated, fibrin d dimer increased, haemorrhage, pelvic fluid collection, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, TIENAM. Patient recovered.

Danaparoid Side Effects Report #5062421-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 20, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, haemorrhage, renal failure, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, PRIMAXIN. Patient recovered.

Danaparoid Side Effects Report #5030468-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 31, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, PRIMAXIN. Patient recovered.

Danaparoid Side Effects Report #5051297-9
Danaparoid side effect was reported by a Health Professional from JAPAN on July 04, 2006. Male patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haemoglobin decreased, haemorrhage, haemorrhagic diathesis, henoch-schonlein purpura, renal disorder, staphylococcal infection . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, DEXPANTHENOL, ALPROSTADIL, MEROPENEM, MINOPHAGEN C, VANCOMYCIN, WARFARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5063639-9
Danaparoid side effect was reported by a Physician from JAPAN on July 18, 2006. Female patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage, myelodysplastic syndrome. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ACLARUBICIN HYDROCHLORIDE, CYTARABINE, GRANISETRON, GABEXATE MESILATE, CEFEPIME HYDROCHLORIDE, AMIKACIN SULPHATE, CARBENIN. Patient died.


Danaparoid Side Effects Report #5031771-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 11, 2005. Female patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ACLARUBICIN HYDROCHLORIDE, CYTARABINE, GRANISETRON, GABEXATE MESILATE, CEFEPIME HYDROCHLORIDE, AMIKACIN SULPHATE, CARBENIN. Patient died.

Danaparoid Side Effects Report #5056233-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 06, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, neoplasm malignant. Danaparoid dosage: unknown. During the same period patient was treated with ULINASTATIN, SIVELESTAT, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, FLOMEX, FAMOTIDINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #4968087-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Nov 19, 2003. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, malignant neoplasm progression. Danaparoid dosage: unknown. During the same period patient was treated with ULINASTATIN, SIVELESTAT, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, FLOMOXEF, FAMOTIDINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #5031766-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 12, 2005. Male patient, 60 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, leukaemia. Danaparoid dosage: unknown. During the same period patient was treated with OMEPRAZOLE, NEO NICHIPHAGEN C, HYDROCORTISONE SUCCINATE, RED BLOOD CELLS, PLASMA PROTEIN FRACTION, NEUPOGEN, IMIPENEM. Patient died.

Danaparoid Side Effects Report #5153401-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 57 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, hepatic function abnormal, multi-organ failure, neoplasm malignant, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, NAFAMOSTAT MESILATE, DOPAMINE, OMEPRAZOLE, CEFOZOPRAN HYDROCHLORIDE, ANTITHROMBIN III, ULINASTATIN. Patient died.


Danaparoid Side Effects Report #4932635-1
Danaparoid side effect was reported by a Health Professional from FRANCE on Feb 21, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anti-platelet antibody positive, catheter site haemorrhage, gastrointestinal haemorrhage, haematoma, haemothorax, leukocytosis, multi-organ failure, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4939443-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematoma, haemothorax, leukocytosis, multi-organ failure, platelet count decreased, post procedural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5329691-8
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on May 10, 2007. Male patient, 58 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage. Danaparoid dosage: unknown. Patient died.